Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo,
early factors include activation of innate immunity, inflammasome activation, oxidative stress …

Diabetes mellitus is a widespread endocrine disease with severe impact on health systems
worldwide. Increased serum glucose causes damage to a wide range of cell types, including …

Vitiligo is a common skin disorder characterized by immune‐mediated destruction of
melanocytes. Non‐segmental vitiligo, the most common clinical subtype, has usually a …

Background Vitiligo is an acquired depigmenting skin disease which is often accompanied
by mental distress. There are numerous studies dedicated to local and global prevalence of …

Vitiligo is a chronic autoimmune disease characterized by loss of pigment of the skin,
affecting 0.5–2% of the population worldwide. It can have a significant impact on patients' …

Understanding autoimmunity of vitiligo and alopecia areata : Current Opinion in Pediatrics
Understanding autoimmunity of vitiligo and alopecia areata : Current Opinion in Pediatrics …

Background Multiple treatment options are introduced in treatment of vitiligo but the
response is unsatisfactory. Objective In this prospective, randomized, comparative trial, we …

Vitiligo is the most common depigmenting disorder characterized by white patches in the
skin. The pathogenetic origin of vitiligo revolves around autoimmune destruction of …